Antimalarial drugs resistance genes of Plasmodium falciparum: a review.


Journal

Annals of parasitology
ISSN: 2299-0631
Titre abrégé: Ann Parasitol
Pays: Poland
ID NLM: 101593588

Informations de publication

Date de publication:
2022
Historique:
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: ppublish

Résumé

Malaria remains the most common parasitic disease on the planet, with 229 million cases and 409,000 deaths worldwide in 2019, including 274,030 children under the age of 5. It is one of the most important infectious diseases in the world and its control is compromised by the spread of the parasite's resistance to antimalarial drugs. This study aims to review the literature of resistant Plasmodium falciparum genes over the past twenty years. One hundred and five (105) articles were collected and read while the resistance of P. falciparum was being studied. Several P. falciparum gene resistances antimalarial drugs were discovered over the past twenty years. The most recent one is the Kelch13 gene of P. falciparum (Pfkelch13) which has showed resistance to artemisinin in Asia. In Africa, this gene represents a potential candidate for resistance to artemisinin, although no resistance was reported.

Identifiants

pubmed: 35809349
doi: 10.17420/ap6802.427
doi:

Substances chimiques

Antimalarials 0
Artemisinins 0
Protozoan Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-225

Auteurs

Chanolle Tchekounou (C)

Laboratoire de Biochimie et Immunologie Appliquées (LABIA), Département de Biochimie-Microbiologie, Université Joseph Ki-Zerbo (UJKZ), Burkina Faso.
Ecole de Santé Sciences Nouvelles (ESSN), Ouagadougou, Burkina Faso.
Institut International des Sciences et Technologie (IISTech), Ouagadougou, Burkina Faso.

Adama Zida (A)

Laboratoire de Parasitologie-Mycologie du Centre Hospitalier Universitaire Yalgado Ouedraogo (CHUYO), Ouagadougou, Burkina Faso.
Ecole de Santé Sciences Nouvelles (ESSN), Ouagadougou, Burkina Faso.
Institut International des Sciences et Technologie (IISTech), Ouagadougou, Burkina Faso.

Cheikna Zongo (C)

Laboratoire de Biochimie et Immunologie Appliquées (LABIA), Département de Biochimie-Microbiologie, Université Joseph Ki-Zerbo (UJKZ), Burkina Faso.
Ecole de Santé Sciences Nouvelles (ESSN), Ouagadougou, Burkina Faso.
Institut International des Sciences et Technologie (IISTech), Ouagadougou, Burkina Faso.

Issiaka Soulama (I)

Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.

Patindoilba M Sawadogo (PM)

Laboratoire de Parasitologie-Mycologie du Centre Hospitalier Universitaire Yalgado Ouedraogo (CHUYO), Ouagadougou, Burkina Faso.
Ecole de Santé Sciences Nouvelles (ESSN), Ouagadougou, Burkina Faso.
Institut International des Sciences et Technologie (IISTech), Ouagadougou, Burkina Faso.

Kiswendsida T Guiguemde (KT)

Centre Hospitalier Universitaire Charles De Gaulles, Ouagadougou, Burkina Faso.

Ibrahim Sangaré (I)

Institut Supérieur des Sciences de la Santé, Université Nazi Boni, Burkina Faso.

Robert T Guiguemde (RT)

Academie Nationale des Sciences, des Arts et des lettres, Ouagadougou, Burkina Faso.

Yves Traore (Y)

Laboratoire de Biochimie et Immunologie Appliquées (LABIA), Département de Biochimie-Microbiologie, Université Joseph Ki-Zerbo (UJKZ), Burkina Faso.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH